Clinical trial
Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
NCT00001893 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001893 |
|---|---|
| Title | Study of TNFR:Fc (Enbrel) in the Treatment of Asthma |
| Official title | A Clinical Trial of TNFR:Fc in a Segmental Allergen Challenge Model of Asthma |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | TNFR:Fc |
| Enrollment | 150 |
| Start date | Aug 17, 1999 |
| Primary completion | Dec 31, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: